Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Short-term Investments: 2009-2025

Historic Short-term Investments for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to $1.4 billion.

  • UNITED THERAPEUTICS's Short-term Investments fell 19.47% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 19.47%. This contributed to the annual value of $1.6 billion for FY2024, which is 12.12% down from last year.
  • According to the latest figures from Q3 2025, UNITED THERAPEUTICS's Short-term Investments is $1.4 billion, which was down 1.93% from $1.5 billion recorded in Q2 2025.
  • UNITED THERAPEUTICS's 5-year Short-term Investments high stood at $1.9 billion for Q4 2022, and its period low was $899.0 million during Q1 2021.
  • Moreover, its 3-year median value for Short-term Investments was $1.6 billion (2023), whereas its average is $1.6 billion.
  • In the last 5 years, UNITED THERAPEUTICS's Short-term Investments surged by 81.24% in 2022 and then fell by 19.47% in 2025.
  • Over the past 5 years, UNITED THERAPEUTICS's Short-term Investments (Quarterly) stood at $1.0 billion in 2021, then skyrocketed by 81.24% to $1.9 billion in 2022, then dropped by 4.85% to $1.8 billion in 2023, then fell by 12.12% to $1.6 billion in 2024, then declined by 19.47% to $1.4 billion in 2025.
  • Its Short-term Investments stands at $1.4 billion for Q3 2025, versus $1.5 billion for Q2 2025 and $1.4 billion for Q1 2025.